Oakland Southfield Physicians currently has 23 practices participating in Cohort 1. Additional practices can enroll in Cohort 2 beginning May 1st.

The mission of the Michigan Collaborative for Type 2 Diabetes (MCT2D) is to work with primary care physicians to prevent and reverse the progression of type 2 diabetes. MCT2D has three key initiatives participating primary care physicians are being asked to implement. The three initiatives are:

1. Expand access to and use of continuous glucose monitoring for type 2 diabetes.
2. Remove barriers to prescribing newer classes of drug treatments for type 2 diabetes, specifically: GLP-1 receptor agonists and SGLT-2 inhibitors.
3. Support lower carbohydrate diets.

Additional practices are eligible for participation in Cohort 2 if they are OSP PCMH PCP offices with an EMR AND are a Provider Delivered Care Management (PDCM) office with 20+ Total T2 Diabetes Blue Cross Patients, OR OSP PCMH PCP offices with an EMR AND are a Physician Group Incentive Program (PGIP) office with 75+ Total T2 Diabetes Blue Cross Patients. Cohort 2 enrollment begins May 1^st and closes July 15^th. Participation in MCT2D results in additional 5% VBR if practice meet specified requirements such as, but not limited to, training requirements, regional meetings, case summaries, learning community activities, etc. during the VBR year. If your practice is interested in learning more about MCT2D Cohort 2 participation, please contact Molly Mason via email at molly@aniosp.com.